At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
In Brief
A clinical study evaluating Continuous Glucose Monitor and Routine Care for Gestational Diabetes and Maternal Complication of Pregnancy. Completed, enrolled 65 participants across 1 site.
Detailed Summary
This study will utilize continuous glucose monitoring in women with A2 gestational diabetes. Women will be randomized to continuous glucose monitoring or routine care with fingersticks to check their blood glucose four times daily. It is hypothesized that women in the continuous glucose monitoring arm will have a lower incidence of the composite primary outcome, which includes the following variables: perinatal death, shoulder dystocia, birth weight greater than 4,000 grams, NICU admission for treatment of hypoglycemia (blood glucose level \<40mg/dL) and birth trauma, including fracture or nerve palsy.
Study Details
Timeline
Interventions
Wearing of a continuous glucose monitor to monitor blood glucose levels in women with gestational diabetes
Use of a glucometer to monitor blood glucose levels in women with gestational diabetes